Audrey Gibson, PA
Medical · Gainesville, GANPI 1053346296
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by AbbVie at 45.4% of the total. 2025 is the largest year on record at $113,142, more than ten times the $8,552 reported in 2021. Among medical clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,231 payments — averaging $245.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$137K
- Johnson & Johnson$76K
- Sanofi$23K
- Boehringer Ingelheim$18K
- Novartis$18K
- Janssen Scientific Affairs, LLC$13K
- plus $17K from 21 others
What the payments were for
- Consulting fees$46,38315%
- Speaking & faculty fees$171,11557%
- Travel & lodging$58,84920%
- Food & beverage$25,2938%
- Education$1370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 564 | $137,092 |
| Johnson & Johnson | 141 | $75,556 |
| Sanofi | 61 | $22,608 |
| Boehringer Ingelheim | 60 | $18,382 |
| Novartis | 114 | $18,123 |
| Janssen Scientific Affairs, LLC | 16 | $12,851 |
| UCB, Inc. | 79 | $6,974 |
| AstraZeneca(2 entities) | 26 | $3,889 |
| Lilly USA, LLC | 7 | $1,682 |
| Eli Lilly | 1 | $1,600 |
| Amgen(2 entities) | 64 | $1,130 |
| E.r. Squibb & Sons, L.L.C. | 30 | $562 |
| Pfizer | 27 | $480 |
| Aurinia Pharma U.S., Inc. | 14 | $243 |
| Sobi, Inc | 2 | $143 |
| GSK | 5 | $88 |
| Genentech USA, Inc. | 4 | $80 |
| Organon | 4 | $69 |
| Actelion Pharmaceuticals US, Inc. | 3 | $42 |
| Fresenius Kabi USA, LLC | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Boston Scientific | 1 | $31 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Merck | 1 | $20 |
| Octapharma USA, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$301,776 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $86,455 |
| Enbrel SureclickEtanercept | 11 | $80,662 |
| Hydroxychloroquine Sulfate | 29 | $1,649 |
| MethotrexateMethotrexate Sodium | 31 | $531 |
| Prednisone | 55 | $511 |
| Diclofenac Sodium | 14 | $130 |
| Tramadol Hcl | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other medical in Gainesville
- Justin SmithGainesville$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
- Danna Dennis-CalderAtlanta$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.